CAS: 71125-38-7 - Meloxicam
Formula:C14H13N3O4S2
InChI:InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
InChI key:InChIKey=ZRVUJXDFFKFLMG-UHFFFAOYSA-N
SMILES:O=C(NC1=NC=C(S1)C)C2=C(O)C=3C=CC=CC3S(=O)(=O)N2C
- Synonyms:
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide
- 2H-1,2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, sodium salt (1:1)
- 4-Hydroxy-2-Methyl-N-(5-Methyl-2-Thiazolyl)-2H-1,2-Benzothiazine-3-Carboxamide 1,1-Dioxide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- Acticam
- Contacera
- Coxflam
- Coxicam
- Emdocam
- Flexicam
- See more synonyms
- Inflacam
- Loxicom
- Maxicam
- Melfax
- Melfax (NSAID)
- Melonex
- Melosus
- Melovem
- Meloxidolor
- Meloxidyl
- Meloxivet
- Meloxoral
- Metacam
- Mobec
- Mobic
- Mobicox
- Movalis
- Movatec
- Novaquin
- Novem
- Novem 5
- Recocam
- RevitaCAM
- Revmoksikam
- Rheumocam
- Sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-2H-1,2-benzothiazin-4-olate 1,1-dioxide
- Uh-Ac 62Xx
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Meloxicam REF: 3D-FH25045CAS: 71125-38-7 | Min 99% | 180.00 €~865.00 € | Wed 15 Jan 25 | |
Meloxicam - Bio-X ™ REF: 3D-BH164661CAS: 71125-38-7 | Min. 95% | 136.00 € | Wed 15 Jan 25 |
Meloxicam
CAS:71125-38-7
COX-2 inhibitor
Formula:
C14H13N3O4S2
Purity:
Min 99%
Color and Shape:
Slightly Yellow Yellow Powder
Molecular weight:
351.4 g/mol
Ref: 3D-FH25045
25g | 180.00 € | ||
50g | 238.00 € | ||
100g | 347.00 € | ||
250g | 633.00 € | ||
500g | 865.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Meloxicam - Bio-X ™
CAS:71125-38-7
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) which is used to treat various types of …
Formula:
C14H13N3O4S2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
351.4 g/mol
Ref: 3D-BH164661
50mg | 136.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025